XML 114 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
Earnings Per Share - Schedule of EPS (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator for EPS      
Net income (loss) $ 46.7 $ 290.5 $ (95.3)
Less: Income attributed to non-controlling interest 26.9 33.4 33.0
Numerator for basic and diluted EPS attributable to Delek $ 19.8 $ 257.1 $ (128.3)
Denominator:      
Weighted average common shares outstanding (denominator for basic EPS) (in shares) 65,406,089 70,789,458 73,984,104
Dilutive effect of stock-based awards (in shares) 569,212 726,903 0
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS) (in shares) 65,975,301 71,516,361 73,984,104
EPS:      
Basic income (loss) per share (in dollars per share) $ 0.30 $ 3.63 $ (1.73)
Diluted income (loss) per share (in dollars per share) $ 0.30 $ 3.59 $ (1.73)
Antidilutive stock-based compensation (because average share price is less than exercise price)      
EPS:      
Antidilutive securities excluded from computation of earnings per share (in shares) 1,718,880 2,299,660 2,988,718
Antidilutive due to loss      
EPS:      
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0 598,775
Total antidilutive stock-based compensation      
EPS:      
Antidilutive securities excluded from computation of earnings per share (in shares) 1,718,880 2,299,660 3,587,493